RxDoctor Payments Data

Ashley Martin

Psychiatric/Mental Health · Macomb, ILNPI 1235534066

Payments from drug & device makers

$1,454in general payments, 2019–2025

Across 91 payments — averaging $15.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$318
  • Otsuka America Pharmaceutical, Inc.$290
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$235
  • Alkermes, Inc.$161
  • Teva Pharmaceuticals USA, Inc.$126
  • E.r. Squibb & Sons, L.L.C.$91
  • plus $232 from 6 others

What the payments were for

  • Food & beverage$1,40797%
  • Education$473%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,454 in reported general payments places this provider in the 70th percentile of 922 psychiatric/mental health providers in Illinois.

See all psychiatric/mental health providers in Illinois

Medicare billing

Part B allowed, 2024
$21,752
Medicare patients
56
Services billed
221

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Austedo XrDeutetrabenazine36$141,092
RexultiBrexpiprazole49$78,739
LybalviOlanzapine/Samidorphan Malate36$59,069
VraylarCariprazine Hcl39$58,610
Aripiprazole41$11,570
Divalproex Sodium ErDivalproex Sodium55$7,523
Ziprasidone Hcl44$6,294
AuvelityDextromethorphan Hbr/Bupropion11$6,026
Desvenlafaxine Succinate ErDesvenlafaxine Succinate23$5,628
Quetiapine Fumarate223$5,560
Lurasidone Hcl13$4,516
Fluoxetine Hcl205$3,078
Clozapine17$2,997
Buspirone Hcl93$2,616
Carbamazepine ErCarbamazepine13$2,234

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo Xr$126$141,09236 claims
Otsuka America Pharmaceutical, Inc.Rexulti$290$78,73949 claims
Alkermes, Inc.Lybalvi$161$59,06936 claims
AbbVieVraylar$318$58,61039 claims
Axsome Therapeutics, Inc.Auvelity$45$6,02611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 922 psychiatric/mental health providers in Illinois.

Other psychiatric/mental health in Macomb

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →